Christopher King Selected Research

Inflammation (Inflammations)

1/2011	Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
12/2009	Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher King Research Topics

Disease

10	Neoplasms (Cancer) 03/2024 - 04/2008
6	Infections 11/2023 - 03/2011
6	Pain (Aches) 01/2022 - 09/2003
4	Malaria 01/2023 - 01/2018
4	Shock 09/2022 - 06/2006
3	COVID-19 01/2023 - 01/2020
3	Wounds and Injuries (Trauma) 09/2022 - 06/2013
3	Prostatic Neoplasms (Prostate Cancer) 05/2020 - 01/2007
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 09/2017
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2011 - 12/2008
2	Pulmonary Hypertension 04/2022 - 11/2021
2	Insulin Resistance 01/2018 - 09/2017
2	Hyperuricemia 01/2018 - 09/2017
2	Allergic Rhinitis 11/2011 - 08/2009
2	Inflammation (Inflammations) 01/2011 - 12/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2007 - 01/2006
1	Filarial Elephantiasis (Lymphatic Filariasis) 11/2022
1	Hydrocephalus (Hydrocephaly) 09/2022
1	Heart Arrest (Cardiac Arrest) 09/2022
1	Pathologic Constriction (Stenosis) 09/2022
1	Meningomyelocele (Myelomeningocele) 09/2022
1	Encephalocele (Encephalocele, Frontal) 09/2022
1	Neural Tube Defects (Exencephaly) 09/2022
1	Hypotension (Low Blood Pressure) 09/2022
1	Pulmonary Arterial Hypertension 04/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Fatigue 01/2022
1	Hemolysis 01/2022
1	Hemorrhage 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Nausea 01/2022
1	Cardiogenic Shock 01/2022
1	Musculoskeletal Pain 01/2022
1	Idiopathic Pulmonary Fibrosis 11/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 11/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2020
1	Tetanus 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Fatty Liver 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2018

Drug/Important Bio-Agent (IBA)

3	FructoseIBA 01/2019 - 09/2017
2	AntigensIBA 01/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	VaccinesIBA 01/2018 - 03/2011
2	ProteomeIBA 01/2018 - 01/2018
2	EphA2 ReceptorIBA 01/2018 - 11/2015
2	prostaglandin D2 receptorIBA 11/2011 - 08/2009
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2007 - 01/2006
1	Blood Group Antigens (Blood Groups)IBA 11/2023
1	Syk KinaseIBA 01/2023
1	Albendazole (Albenza)FDA Link 11/2022
1	Diethylcarbamazine (Hetrazan)FDA Link 11/2022
1	Ivermectin (Mectizan)FDA Link 11/2022
1	ORALIT (ORS)IBA 09/2022
1	antineoplaston A10 (A 10)IBA 09/2022
1	Midazolam (Versed)FDA LinkGeneric 09/2022
1	Ketamine FDA LinkGeneric 09/2022
1	poly(2-hydroxyethyl acrylate) (PHEA)IBA 09/2022
1	Phosphodiesterase 5 InhibitorsIBA 04/2022
1	Endothelin Receptor AntagonistsIBA 04/2022
1	riociguatIBA 04/2022
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 04/2022
1	Pain-FreeIBA 01/2022
1	treprostinil FDA Link 11/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2020
1	AntibodiesIBA 01/2020
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2019
1	letermovirIBA 12/2019
1	Valganciclovir FDA Link 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019
1	Interleukin-7 (Interleukin 7)IBA 01/2019
1	SugarsIBA 01/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2019
1	Immunoglobulin A (IgA)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018

Therapy/Procedure

6	Therapeutics 04/2022 - 01/2007
4	Radiotherapy 05/2020 - 01/2007
3	Critical Care (Surgical Intensive Care) 09/2022 - 06/2013
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2011 - 12/2008
2	Immunotherapy 03/2024 - 04/2008
2	Craniotomy 09/2022 - 10/2010
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Cannula 01/2023
1	Mass Drug Administration 11/2022
1	Laminectomy 09/2022
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Thrombectomy 01/2022
1	Meditation 01/2022
1	Lung Transplantation 11/2021
1	Particle Accelerators 05/2020
1	Cell Transplantation 12/2019
1	Pain Management 01/2019